Gland Pharma Limited (GLAND) — Board Meeting
Gland Pharma disclosed that independent director Satyanarayana Murthy Chavali resigned effective June 15, 2026, citing a potential conflict of interest arising from his promoter role in a company planning to enter a business segment overlapping with Gland Pharma's future plans. The resignation letter confirmed no other material reasons, and the company requested board acknowledgment for statutory filings.
About Gland Pharma Limited (GLAND)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GLAND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLAND — Free💡 Ask AI about this filing
📊 More GLAND filings
- Financial Results — 26 June 2026 Gland Pharma announced that its trading window will close on June 27, 2026, ahead of the unaudited q...
- Announcement — 22 June 2026 Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings, includ...
- 🟡 Voting Results — 18 June 2026 Gland Pharma Limited's shareholders approved the reappointment of Udo Jahannes Vetter as Independent...
- Announcement — 17 June 2026 Gland Pharma announced a schedule of analyst and institutional investor meetings, including a one-on...
- 🟡 Board Meeting — 15 June 2026 Gland Pharma announced board changes effective June 15, 2026, reappointing Udo Jahannes Vetter as In...
🔥 Also filed on 16 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GLAND files new disclosures
Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLAND — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research